These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 12842627)
1. Development of adenovirus serotype 35 as a gene transfer vector. Seshidhar Reddy P; Ganesh S; Limbach MP; Brann T; Pinkstaff A; Kaloss M; Kaleko M; Connelly S Virology; 2003 Jul; 311(2):384-93. PubMed ID: 12842627 [TBL] [Abstract][Full Text] [Related]
2. [Development of a replication-incompetent adenovirus vector derived from subgroup B adenovirus serotype 35]. Sakurai F Yakugaku Zasshi; 2008 Dec; 128(12):1751-61. PubMed ID: 19043294 [TBL] [Abstract][Full Text] [Related]
3. [Characterization of adenovirus serotype 35 vectors using genetically modified animals and non-human primates]. Sakurai F; Kawabata K; Mizuguchi H Yakugaku Zasshi; 2006 Nov; 126(11):1013-9. PubMed ID: 17077607 [TBL] [Abstract][Full Text] [Related]
4. Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector. Sakurai F; Mizuguchi H; Yamaguchi T; Hayakawa T Mol Ther; 2003 Nov; 8(5):813-21. PubMed ID: 14599815 [TBL] [Abstract][Full Text] [Related]
5. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype. Mack CA; Song WR; Carpenter H; Wickham TJ; Kovesdi I; Harvey BG; Magovern CJ; Isom OW; Rosengart T; Falck-Pedersen E; Hackett NR; Crystal RG; Mastrangeli A Hum Gene Ther; 1997 Jan; 8(1):99-109. PubMed ID: 8989999 [TBL] [Abstract][Full Text] [Related]
6. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models. Wohlfahrt ME; Beard BC; Lieber A; Kiem HP Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719 [TBL] [Abstract][Full Text] [Related]
7. Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors. Greig JA; Buckley SM; Waddington SN; Parker AL; Bhella D; Pink R; Rahim AA; Morita T; Nicklin SA; McVey JH; Baker AH Mol Ther; 2009 Oct; 17(10):1683-91. PubMed ID: 19603000 [TBL] [Abstract][Full Text] [Related]
8. Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector. Sakurai F; Mizuguchi H; Hayakawa T Gene Ther; 2003 Jun; 10(12):1041-8. PubMed ID: 12776162 [TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of a novel gene delivery vehicle composed of adenovirus serotype 35. Sakurai F Biol Pharm Bull; 2008 Oct; 31(10):1819-25. PubMed ID: 18827334 [TBL] [Abstract][Full Text] [Related]
10. Alternate serotype adenovector provides long-term therapeutic gene expression in the eye. Hamilton MM; Byrnes GA; Gall JG; Brough DE; King CR; Wei LL Mol Vis; 2008; 14():2535-46. PubMed ID: 19122827 [TBL] [Abstract][Full Text] [Related]
11. Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35. Sakurai F; Nakashima K; Yamaguchi T; Ichinose T; Kawabata K; Hayakawa T; Mizuguchi H J Control Release; 2010 Dec; 148(2):212-8. PubMed ID: 20800630 [TBL] [Abstract][Full Text] [Related]
12. Development of a novel adenovirus serotype 35 vector vaccine possessing an RGD peptide in the fiber knob and the E4 orf 4, 6, and 6/7 regions of adenovirus serotype 5. Onishi R; Ikemoto S; Shiota A; Tsukamoto T; Asayama A; Tachibana M; Sakurai F; Mizuguchi H Int J Pharm; 2024 Sep; 662():124480. PubMed ID: 39038719 [TBL] [Abstract][Full Text] [Related]
16. Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity. Vogels R; Zuijdgeest D; van Rijnsoever R; Hartkoorn E; Damen I; de Béthune MP; Kostense S; Penders G; Helmus N; Koudstaal W; Cecchini M; Wetterwald A; Sprangers M; Lemckert A; Ophorst O; Koel B; van Meerendonk M; Quax P; Panitti L; Grimbergen J; Bout A; Goudsmit J; Havenga M J Virol; 2003 Aug; 77(15):8263-71. PubMed ID: 12857895 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46. Wang H; Liu Y; Li Z; Tuve S; Stone D; Kalyushniy O; Shayakhmetov D; Verlinde CL; Stehle T; McVey J; Baker A; Peng KW; Roffler S; Lieber A J Virol; 2008 Nov; 82(21):10567-79. PubMed ID: 18753195 [TBL] [Abstract][Full Text] [Related]
18. Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice. Smith TA; Idamakanti N; Rollence ML; Marshall-Neff J; Kim J; Mulgrew K; Nemerow GR; Kaleko M; Stevenson SC Hum Gene Ther; 2003 May; 14(8):777-87. PubMed ID: 12804140 [TBL] [Abstract][Full Text] [Related]
19. Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes. Mizuguchi H; Hayakawa T Gene; 2002 Feb; 285(1-2):69-77. PubMed ID: 12039033 [TBL] [Abstract][Full Text] [Related]